The report studies the U.S. Ketamine market from 2007 to 2015 and anticipates moderate growth from 2011 to 2016. Anesthesia drugs included in the report are propofol, midazolam, diazepam and more.
The U.S. general anesthesia market was worth approximately $2 billion in 2011 and should grow 4 percent. Anesthetic drugs account for 65 percent of the general anesthetic drug market.
More Articles on Anesthesia:
Dr. Robert Brooker of Sheridan Healthcare to Discuss Blood Conservation at ASA Meeting
Dr. Mark Romanoff Nominated as Physician of the Year Finalist
Anesthesiologist Updates for Oct. 1, 2014
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
